DOCSLIB.ORG

Caries Risk Assessment

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Caries Risk Assessment OCTOBER CAMBRA Clinical Protocols Journal Products - Caries risk assessment Douglas A. Young, DDS, MS, MBA; John D.B. Featherstone, MSc, PhD; and Jon R. Roth, MS, CAE CDA Journal Volume 35, Number 10 Journal october 2007 departments 665 The Editor/Health Illiteracy 667 Letters to the Editor 671 Impressions 754 Dr. Bob/Dental Spa-ahhhhh features 679 CARIES MANAGEMENT BY RISK ASSESSMENT — A PRACtitioner’S GUIDE An introduction to the issue. Douglas A. Young, DDS, MS, MBA; John D.B. Featherstone, MSc, PhD; and Jon R. Roth, MS, CAE 681 CURING THE SILENT EPIDEMIC: CARIES MANAGEMENT IN the 21sT CENTURY AND BEYOND This paper will present key concepts necessary for the most current management of dental caries and sets the stage for subsequent papers in this issue to cover the clinical implementation of a caries management by risk assessment model (CAMBRA). Douglas A. Young, DDS, MS, MBA; John D.B. Featherstone, MSc, PhD; and Jon R. Roth, MS, CAE 687 CARIES RISK ASSESSMENT APPROPRIATE FOR THE Age 1 VISIT (INFANTS AND Toddlers) The latest maternal and child Caries Management By Risk Assessment tools for children age 0 to 5 (CAMBRA 0-5), developed for oral health promotion and disease prevention starting with the recommended age 1 dental visit is presented in this paper. Francisco J. Ramos-Gomez, DDS, MS, MPH; James Crall, DDS, ScD; Stuart A. Gansky, DrPH; Rebecca L. Slayton, DDS, PhD; and John D.B. Featherstone, MSc, PhD 703 CARIES RISK ASSESSMENT IN PRACTICE FOR Age 6 THROUGH ADULT A practical caries risk assessment procedure and form for patients age 6 through adult are presented. The content of the form and the procedures have been validated by outcomes research after several years of experience using the factors and indicators that are included. John D.B. Featherstone, MSc, PhD; Sophie Domejean-Orliaguet, DDS; Larry Jenson, DDS, MA; Mark Wolff, DDS, PhD; and Douglas A. Young, DDS, MS, MBA 714 CLINICAL PROTOCOLS FOR CARIES MANAGEMENT BY RISK ASSESSMENT This article seeks to provide a practical, everyday clinical guide for managing dental caries based upon risk group assessment. Also included are some sample treatment plans to help practitioners visualize how CAMBRA may impact a patient’s treatment. Larry Jenson, DDS, MA; Alan W. Budenz, MS, DDS, MBA; John D.B. Featherstone, MSc, PhD; Francisco J. Ramos-Gomez, DDS, MS, MPH; Vladimir W. Spolsky, DMD, MPH; and Douglas A. Young, DDS, MS, MBA 724 PRODUCTS: OLD, NEW, AND EMERGING The purpose of this review is to present the evidence base for current products and those that have recently appeared on the market. Vladimir W. Spolsky, DMD, MPH; Brian Black, DDS; and Larry Jenson, DDS, MS Editor CDA JOURNAL, VOL 35, N 1 0 º Health Illiteracy ALAN L. FELSENFELD, DDS uch has been written about health literacy in recent The promontora programs are an example of months. The October 2006 issue of the Journal of Ameri- attempts to overcome the difficulty of health can Dental Association had an Meditorial by Dr. Michael Glick supporting literacy in selected populations. efforts to alleviate the increasing amount of health illiteracy. That same year, the American Dental Association established a committee to study the problem and access to health care. These are people their ability to communicate with their report back to the 2007 House of Del- who may have substantial difficulty in the patients and ensure a depth of under- egates. The committee was charged to comprehension of health care concepts, standing. Providers need to understand assist the Council on Access, Prevention a lack of individuals to attempt to teach cultural values and systems for their and Interpersonal Relations in developing them, or language barriers. As a result, potential patient populations. Social programs and identifying approaches to there is likely to be a less aggressive use mores and beliefs need to be addressed enabling this all-important concept. The of available facilities and personnel for in the planning for health care programs Association took a good approach to the health care or lack of adequate preventive and delivery. We need to update ourselves problem, not so much in the establish- practices on their part. The promontora continually on techniques that enable us ment of a group to look at the problem programs are an example of attempts to to relate to our patients who have cultural but rather their charge relative to the overcome the difficulty of health literacy differences to be effective in educating definition of the issue. in selected populations by using local them on health matters. The American Illiteracy can be viewed at three levels. community health care workers to edu- Dental Association has charged the Coun- For some, there is difficulty in compre- cate the masses. Caregivers for the elderly cil on Dental Education and Licensure to hending the necessity of good health or the infirm are another area where encourage development of programs to practices. This level of illiteracy is difficult health literacy can be promoted. Ad- train health care professionals in preven- to overcome in that the individuals may ditional programs such as these need to tive care for patients. not be able to understand the information continue to be developed for future pre- The final level of illiteracy is igno- they are given. For others, there may be vention and treatment of dental, as well rance. The lack of ability to learn in our a lack of education. These are individuals as general health issues. Patients need to patients or lack of education for our who have the capacity to learn but have be educated on the need for proper diet, health care providers, while unfortunate, not been taught or have learned errone- oral hygiene, and utilizing dental profes- is understandable and somewhat excus- ous things. Finally, there is ignorance for sionals and facilities to prevent problems able. Ignorance, the process of ignoring those who are educated and ignore that and treat disease. what is known, is not. The programs for which they have learned. This ignorance is The uneducated groups might include health care at the government level and a blatant disregard of evidence in fact for those who deliver health care. Physi- with private carriers cannot be excused various reasons. cians, nurses, dentists, hygienists, dental for ignoring the people who need health Recipients of outreach programs are assistants, and others certainly have the care at the most basic level. Federal, state, the poor, working poor, undocumented knowledge to inculcate health care values and local programs need to reassess their immigrants, language-challenged citizens, in their patients. Lacking may be cultural priorities for inclusion and reimburse- elderly and those who have limited or no sensitivity and language skills that foster ment for dental and general health care. OCTOBER 2007 665 CDA JOURNAL, VOL 35, N º 1 0 Then, and only then, can we say that we are progressing from illiteracy to literacy. Health literacy is a multilevel issue that has impact in California as well as nationally. It involves patients, provid- ers, and payers. It reflects a meshing of values at all three levels that ultimately will improve the health of the population. This is a significant problem that needs to be addressed if we are to continue to ad- dress prevention of disease in the patient populations who most need it. REFERENCES 1. Glick M, The tower of Babel and health outcomes. J Am Dent Assoc 137(10):1356-8, 2006. Address comments, letters, and questions to the editor at [email protected]. 666 OCTOBER 2007 Letters CDA JOURNAL, VOL 35, N 1 0 º Kudos for the New AHA Endocarditis Prevention Guidelines he Journal of the California scribe them — go away ... ” At some point number of dental procedures for which Dental Association should be in time, I think dentistry needs to make prophylaxis is indicated has also enlarged commended for the excellent the point that we are every bit as much from previous recommendation in this article by Dr. Thomas Pal- “doctors” as they are, and we need to tell select high-risk group. lasch regarding the new AHA our patients what to do based on research The American Academy of Oral Medi- Tendocarditis prevention guidelines. Dr. and not based on what individual medical cine supports these recommendations Pallasch’s analysis of the situation was ex- practitioners tell us what to do. and would like to assist dentists in mak- cellent. But his article begs some needed It is my prediction that it will take ing the transition to the new guidelines issues and questions … years for MDs to stop telling their as smooth as possible. This article then . Knowing that the evidence for patients they need antibiotics prior to is not intended as a substitute for an in- antibiotic prophylaxis was lacking, why dental procedures, in spite of the new depth review of these important changes did we as a profession bow to the medi- AHA recommendations. but an aid in the process of making the cal profession’s demands for something GUY G. GIACOPUZZI, DDS transition to the new regimen. that was truly dangerous for our patients? Lake Arrowhead, Calif. Included are two documents that The needless antibiotic prescribing has should assist in this process. The first is a certainly bred resistant bacteria and summary for posting in one’s office or in generated allergic reactions. We’ve had NO DOUBT a clinical area as a reminder of just what the science to support the “no-antibiot- conditions are now covered, for what ics-necessary” position for a number of the word will procedures, and with what medications. years. Had ADA come up with an official eventually spread This one-page sheet is intended to cue position, I think we could have not only providers in their daily practice.
Load more

Recommended publications
  • Mouth Rinses
    Mouth Rinses We may recommend a mouth rinse to you for one or more of the following reasons: Periodontal Disease, Gingivitis, Halitosis (bad breath), sensitive teeth, decay or increased risk of decay, dry mouth, minor mouth sore or irritation. Red= RX only Blue= Available through your dentist only Green= Over the counter *Common side effects found with many mouth rinses include the possibility of staining. We still encourage you to use the rinse that treats your problem because none of the stains these rinses cause are permanent. With good oral hygiene on your part, using your bleaching trays and bleach as needed, you can keep the staining to a minimum. If there is any staining that you can’t prevent, it can always be easily removed by your hygienist at your next cleaning. If you have periodontal disease or Gingivitis, we may recommend an antimicrobial/antiseptic type rinse. These rinses kill germs, reduce plaque, redness, swelling and bleeding when used in conjunction with proper brushing and flossing. Some common examples of antiseptic rinses are: Peridex or Perioguard oral rinses are available by prescription only. Active ingredient is chlorhexidine gluconate .12%. These also contain alcohol 11.6%. Can cause staining of the teeth*, taste alteration and dry mouth. Periomed Oral rinse is available through your dentist only. Active ingredient is stannous fluoride .63%. It is alcohol free. Periomed provides antimicrobial activity for up to 8 hours. Also promotes enamel remineralization, and helps reduce sensitivity. Can cause staining* and dry mouth. Listerine Antiseptic: Active ingredient is alcohol 26.9% in the original gold Listerine, and 21.6% in the other flavors.
    [Show full text]
  • 1 Brief Report: the Virucidal Efficacy of Oral Rinse Components Against SARS-Cov-2 in Vitro Evelina Statkute1†, Anzelika Rubin
    bioRxiv preprint doi: https://doi.org/10.1101/2020.11.13.381079; this version posted November 13, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. Brief Report: The Virucidal Efficacy of Oral Rinse Components Against SARS-CoV-2 In Vitro Evelina Statkute1†, Anzelika Rubina1†, Valerie B O’Donnell1, David W. Thomas2† Richard J. Stanton1† 1Systems Immunity University Research Institute, Division of Infection & Immunity, School of Medicine, Heath Park, Cardiff, CF14 4XN 2Advanced Therapies Group, School of Dentistry, Cardiff University, Heath Park, Cardiff CF14 4XY, UK †These authors contributed equally * Correspondence: [email protected], [email protected] Running title: Virucidal Activity of Mouthwashes Keywords: SARS-CoV2, mouthwash, lipid, envelope Disclosure: Venture Life Group plc provided information on mouthwash formulations employed in the study, but had no role in funding, planning, execution, analysis or writing of this study. A separate study funded to Cardiff University by Venture Life Group is assessing in vivo efficacy of CPC in patients with COVID19. The investigators declare no direct conflicts exist. 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.11.13.381079; this version posted November 13, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license.
    [Show full text]
  • Caries Vaccine: an Overview Dr
    Saudi Journal of Oral and Dental Research Abbreviated Key Title: Saudi J Oral Dent Res ISSN 2518-1300 (Print) |ISSN 2518-1297 (Online) Scholars Middle East Publishers, Dubai, United Arab Emirates Journal homepage: https://saudijournals.com/sjodr Review Article Caries Vaccine: An Overview Dr. Charvi Gupta*, Dr. Hemant Mankel Assistant Professor, Mekelle University, Ethiopia DOI: 10.36348/sjodr.2020.v05i05.003 | Received: 13.05.2020 | Accepted: 20.05.2020 | Published: 23.05.2020 *Corresponding author: Dr. Charvi Gupta Abstract One of the most common diseases in humans is dental caries. It is an infectious disease of microbiological origin that results in localized dissolution and destruction of the calcified tissue of teeth. It is a diseased caused by multitude of factors like host, agent and environmental factors. Microbes like S. mutans, Lactobacillus acidophilus and Actinomyces viscosus are the main pathogenic species involved with initiation and progression of dental caries. Indian surveys demonstrate caries prevalence of 58% in school children. Among the U.S. Population surveys showed 45.3% children and 93.8% of adults. A large costing of dental treatments whether prevention using remineralizing agents and treatment using restorative materials can be reduced if we could eradicate dental caries completely. Thus the ultimate objective of community health is the complete elimination of this disease. Development of dental caries vaccines is a boon for eradication of this microbiological disease. Keywords: Dental caries, infectious disease, microbes, S.mutans, prevention, dental caries vaccines. Copyright @ 2020: This is an open-access article distributed under the terms of the Creative Commons Attribution license which permits unrestricted use, distribution, and reproduction in any medium for non-commercial use (NonCommercial, or CC-BY-NC) provided the original author and source are credited.
    [Show full text]
  • Listerine Floss Product Chart EN V9black
    RECOMMEND LISTERINE® EFFECTIVE MOUTHRINSES FOR A WHOLE MOUTH CLEAN® 3 ANTISEPTIC ANTICAVITY 2X MORE HEALTHY SITES VS. JUST BRUSHING & FLOSSING WHITENING ALL-IN-ONE ONLY LEADING BRAND THAT THE MOST COMPLETE RINSE WHITENS & STRENGTHENS ALL-IN-ONE ZERO ALL-IN-ONE ANTI-CAVITY PEROXIDE WHITENS AND WHITENS AND CLASSIC ANTI-STAIN ANTI-TARTAR ANTI-CAVITY ALL-IN-ONE FOR SENSITIVE ALCOHOL TEETH ZERO ALCOHOL ZERO ALCOHOL FREE STRENGTHENS STRENGTHENS METERED DOSING FOR KIDS FEATURES ® LISTERINE LISTERINE LISTERINE LISTERINE LISTERINE LISTERINE LISTERINE LISTERINE LISTERINE LISTERINE LISTERINE LISTERINE LISTERINE TOTAL CARE HEALTHY HEALTHY HEALTHY ULTRACLEAN ULTRACLEAN ULTRACLEAN TOTAL CARE SMART RINSE ZERO TOTAL CARE FOR SENSITIVE WHITE™ WHITE™ WHITE™ BRAND ANTI-STAIN ANTI-TARTAR ANTI-CAVITY TEETH ZERO FOR KIDS GENTLE RESTORING VIBRANT COOL MINT BERRY FRESHBURST ARCTIC MINT BUBBLE GUM FLAVOURS MILD MINT COOL MINT FRESHBURST CLEAN MINT CLEAN MINT MILD MINT CLEAN MINT CLEAN MINT CLEAN MINT ORIGINAL COOL CITRUS MINT EUCALYPTOL 0.091% W/V MENTHOL 0.042% W/V THYMOL 0.063% W/V SODIUM FLUORIDE SODIUM SODIUM 0.02% W/W FLUORIDE FLUORIDE ACTIVE SODIUM FLUORIDE 0.022% W/V SODIUM TETRAPOTASSIUM 0.022% W/V 0.02% W/W FLUORIDE PYROPHOSPHATE INGREDIENTS ZINC CHLORIDE 0.09% W/V ZINC CHLORIDE POTASSIUM ZINC CHLORIDE 0.022% W/V PENTASODIUM HYDROGEN PEROXIDE 0.09% W/V NITRATE 2.4% W/V 0.09% W/V TRIPHOSPHATE KILLS UP TO 99.9% OF GERMS IN YOUR MOUTH PREVENTS & REDUCES GINGIVITIS PREVENTS & REDUCES PLAQUE SAFELY WHITENS TEETH† PREVENTS CAVITIES MILD FLAVOUR HELPS KEEP PREVENTS CAVITIES PRODUCT TEETH WHITE STRENGTHENS STRENGTHENS TOOTH ENAMEL* 2X BETTER TOOTH ENAMEL CAVITY ATTRIBUTES PROTECTION VS.
    [Show full text]
  • July 21, 2021
    1 2nd Quarter 2021 Earnings Call July 21, 2021 Cautionary Note on Forward-looking Statements This presentation contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things: future operating and financial performance, product development, market position and business strategy. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Johnson & Johnson. Risks and uncertainties include, but are not limited to: risks related to the impact of the COVID-19 global pandemic, such as the scope and duration of the outbreak, government actions and restrictive measures implemented in response, material delays and cancellations of medical procedures, supply chain disruptions and other impacts to the business, or on the Company’s ability to execute business continuity plans, as a result of the COVID-19 pandemic; economic factors, such as interest rate and currency exchange rate fluctuations; competition, including technological advances, new products and patents attained by competitors; challenges inherent in new product research and development, including uncertainty of clinical success and obtaining regulatory approvals; uncertainty of commercial success for new and existing products; challenges to patents; the impact
    [Show full text]
  • Milestone Guide and Workbook
    Tulsa County Family Treatment Court Milestone Guide and Workbook 6th Edition May 2019 Tulsa County Family Treatment Court Table of Contents Milestone 0 Orientation Milestone 0 Checklist 3 Family Treatment Court Contract 4-6 Consent for Re-disclosure of Confidential Information 7 Medical Compliance Form 8 Family Treatment Court Countdown to Sobriety Worksheet 9 Drug Testing Program Requirements 10 Urine Analysis Collection Policy and Procedures 11 Courtroom Rules and Treatment Court Important Points to Remember 12 Client Information Sheet 13 Court Dress Code 14 Prescription Drug Policy 15-16 Doctors, Medicine, and Family Treatment Court Information 17 Approved Over the Counter Medication List 18 Milestone 1 White Belt Milestone 1 Checklist 19-20 Important Contact Information 21 Appointment Scheduler Worksheet 22 Rules for Mentees and Mentors 23-24 What are You Strengths? 25 Taking Care of Me 26 Appendix A 211 Information Packet Appendix B Narcotics Anonymous and Alcoholics Anonymous Meeting Information 2 Tulsa County Family Treatment Court Milestone 0 White Belt Orientation and Introduction Drug Test Color: Gold Completed orientation packet o Contract o Release of Confidential Information o Medical Compliance o Drug Testing Program Requirements o UA Collection o Client Information Sheet Received o Courtroom Rules o Dress Code o Prescription Drug Policy o Doctor, Medicine, and FTC info sheet Received White wrist band Issued FTC Guidebook binder Recognized to court. You starting court date is: Sober date: Your date to start drug testing is: The color line number is 918-596-8737 Drug testing is done at DATL o (2626 S. Sheridan, phone: 918-664-3285) 3 Tulsa County Family Treatment Court Family Treatment Court Contract I, _______________________________, have been accepted as a voluntary participant in the Tulsa County Family Treatment Court Program.
    [Show full text]
  • TITLE Safety and Efficacy of Over-The-Counter Drug Use by the Elderly
    " DOCUMENT RESUME ED 245 148 CG 017 518 TITLE Safety and Efficacy of Over-the-Counter Drug Use by the Elderly. Hearing before the Subcommittee on Health and Long-Term Care of the Select Committee on Aging. House of Representatives, Ninety-Eighth Congress, First Session. INSTITUTION Congress of the U.S., Washington, D.C. House Select Committee on Aging. REPORT NO House-Comm-Pub-98-409 PUB DATE 21 Jul 83 NOTE 507p.; Some pages are marginally legible due to small print. PUB TYPE Legal/Legislative/Regulatory Materials (090) EDRS PRICE MF02 Plus Postage. PC Not Available from EDRS. DESCRIPTORS *Consumer Protection; Dietetics; Drug Legislation; *Drug Use; Gerontology; Hearings; *Older Adults; Physical Health; *Safety IDENTIFIERS Congress 98th; Long Term Care; *Nonprescription Drugs; *PPA ABSTRACT This document contains the prepared statements and panel testimony from the Congressional hearing on over-the-counter (OTC) drug use by the elderly. Opening statements are given by Representatives Claude Pepper (chairman), Ralph Regula, Mary Rose Oakar, Michael Bilirakis, Tom Lantos, and Hal Daub. Topics which are covered include the incidence and quantity of drug use by the elderly, health risks, adverse reactions, phenylpropanolamine (PPA), consumer protection, and the Federal Drug Administration's (FDA) role in the OTC drug safety and reguIatiem. Testimony of the first panel on OTC drugs, particularly weight reduction medications containing PPA, is given by representatives of the Health Research Group, the National Broadcasting Company, and consumers. Testimony of the second panel on mail fraud schemes perpetrated against senior citizens is given by consumer advocates representing the United States Postal Service, Criminal Investigations and Consumer Protection Divisions, and the Center for Science in the Public Interest.
    [Show full text]
  • 2019 SMDP Biotech Training Agenda & Scholar Bios
    2019 SMDP Biotech 1-5 June PHILADELPHIA www.icpdprograms.org 2019 Scientist Mentoring & Diversity Program for biotechnology (SMDP Biotech) www.icpdprograms.org Training Session June 1-6, 2019 in Philadelphia, PA about the program who attends: the one-year career mentoring program pairs ethnically diverse post-baccalaureate students, graduate students and post-doctoral researchers with industry mentors who work at biotechnology and consumer healthcare companies. With their mentors, SMDP Biotech Scholars attend a 5-day training session to learn about career opportunities in industry and receive career coaching. SMDP Scholars and Mentors also attend The BIO International Convention. how to dress, what to bring: business attire with comfortable shoes. Scholars, bring 100 business cards and 10 copies of your resume. Mentors will need business cards too. Informal dinner where to go: SMDP training Scholars and Mentors you’re Host Hotel session day 1 already on the guest list, we Mentors you will arrange the bus leaves the leave J&J Consumer at 5:15pm your own accommodation host hotel at 6:30am Ladder 15, 1528 Sansom Street, Scholars a shared room Scholars you will be Philadelphia, PA 19102 reservation has already been introduced to your made for you at this location: Mentors at the Reading Terminal MarKet Philadelphia 201, 201 N. 17th training session The bus leaves from the SMDP J&J Consumer, Street, Philadelphia, PA 19103 training session at 11:30am 199 Grandview Road, Corner of North 12th Street “Celebration of Mentoring Skillman, NJ 08558 and Arch Street (South Bldg. SK1912) & Diversity” reception ($10 will be provided) (Saturday, June 1st at 6pm) SMDP training The BIO Intl Convention Scholars and Mentors you’re session day 2 registration information will be already on the guest list the bus leaves the provided during the SMDP The Pyramid Club, host hotel at 7am training session.
    [Show full text]
  • Creative Director 561.714.1585 Andy Mathurin
    Hello, I am: Looking for role as: Let’s Connect: Andy Mathurin Creative Director 561.714.1585 Associate Creative Director, [email protected] Brand Strategist New York What I do: PROFILE Brand Strategy Over 8 years leading branding and marketing concepts with career spanning 360 campaigns, broadcast, print, OOH, social, digital, video and experiential Identity Design across major worldwide brands. Energetic and a creative visionary offering Storytelling demonstrated expertise in all aspects of branding and strategy, with core focus Thought Leader on delivering business results. Team Builder Marketing WINS Project Management Successes have included winning several accounts for new business, resulting in agency being awarded Global Agency of the Year by AdAge & Adweek. Toolkit: AOR: Havas - Vascepa 2019, Havas - Alcon 2019, J3 - OGX 2018, UM - H&M 2017, UM - Sony 2017, BMW 2016, UM - Coca Cola 2016 Sketch XD Microsoft Office PROFESSIONAL EXPERIENCE Avocode 03.18 HAVAS | Manhattan, NY Photoshop Present Associate Creative Director Strategic partner, focusing on brand equity for healthcare and InDesign pharmaceutical brands. Responsible for new business and leading creative Illustration team/studio across all digital platforms (specializing in social). After Effects Brands include: Zicam, Alcon, GSK, NUCALA, TRELEGY, & ANORO. 09.14 Universal McCann Worldwide | Manhattan, NY 03.18 Personality: Associate Creative Director + Senior Art Director Hands-on leader in identity design. Champion participant in winning new Human business pitches. Guiding and advising clients on high-level executions. Confident Brands include: Sony Pictures, GoPro, McCormick, BMW... and more. Effective Communicator - Demonstrate strong leadership overseeing staff in the day-to-day projects Motivational Honest with Integrity - Deliver against demanding brand objectives and develop creative that Empathetic exceeds business needs, managing projects from concept through completion: timelines, budgets, schedules, etc.
    [Show full text]
  • Caries Vaccine REVIEW ARTICLE
    Singh S et al.: An Insight into Caries Vaccine REVIEW ARTICLE An Insight into Caries Vaccine Shilpa Singh1, Sakshi Kataria2 Correspondence to: 1- B.D.S, S.G.T Dental College and Research Centre, Gurgaon, Haryana. 2- B.D.S, Dr. Shilpa Singh, B.D.S, S.G.T Dental College and M.D.S, Dept of Public Health Dentistry, Sudha Rastogi College of Dental Sciences and Research Centre, Gurgaon, Haryana. Research, Faridabad, India. Contact Us: www.ijohmr.com ABSTRACT Dental Caries is a microbiologic disease that depends on various factors like host, agent and environment. The Colonization of S. mutans occurs in the oral cavity at the age of 2-3 years. This period is known as Window of Infectivity. Different preventive approaches have been laid for the prevention of Dental Caries, among which Caries Vaccine is the one which has caught researchers’ attention at present. Immunization can be both active or passive. The targets of vaccine are proteinous substances that are present on bacterial surface, enzymes. Immunity is achieved by concentration of immune response on suspected functional areas of targeted components by using synthetic peptides and recombinant DNA Technology. Application on human depend on the successful animal trials. KEYWORDS: Vaccine, Mutans Streptococci, Immunoglobin, Recombinant DNA Technology AA aaaasasasss INTRODUCTION Dental Caries which is considered as a major public exposed to modest maternal challenge have health problem, is caused by interaction between host, approximately 50% bacterial colonization and children diet, environmental factors and time.1 Numerous studies exposed to high maternal levels have approximately 90% have been conducted on determining the etiology of colonization.
    [Show full text]
  • Propylene Glycol
    PROPYLENE GLYCOL Your patch test result indicates that you have a contact allergy to propylene glycol. This contact allergy may cause your skin to react when it is exposed to this substance although it may take several days for the symptoms to appear. Typical symptoms include redness, swelling, itching, and fluid-filled blisters. Where is propylene glycol found? Propylene glycol is used as a softening agent, preservative, humectants, and solvent in cosmetics, fragrances, topical medications, soaps and cleansers, hair care products, and deodorants. Propylene glycol is also found in oral treatments as well as many foods. It is also added during the manufacture of many industrial fluids, such as solvents, thinners, antifreeze, other de-icing fluids, desiccants, brake fluids, and polyester resins. How can you avoid contact with propylene glycol? Avoid products that list any of the following names in the ingredients: • Propylene glycol • 1,2-Dihydroxypropane • CASRN: 57-55-6 • Methylethyl glycol • 1,2-Propanediol • 2-Hydroxypropanol • Isopropylene glycol What are some products that may contain propylene glycol? Antiperspirants and Deodorants: • Old Spice High Endurance • Meguiars Vinyl/Rubber Cleaner/Condition • Adidas 24 Hour Deodorant Control Antiperspirant & Deodorant • Pennzoil Roadside Fix A Flat Tire Sealant & • Adidas 24 Hour Fragrance Clear Stick • Old Spice High Endurance Deodorant Flat Preventative Deodorant • Old Spice Red Zone Clear Gel • Rain-X De-Icer (Aerosol) • Adidas Action 3 Tech F • Old Spice Red Zone Deodorant Stick • Slime
    [Show full text]
  • Universal COVID-19 Vaccine Targeting SARS-Cov-2 Envelope Protein
    World Journal of Vaccines, 2021, 11, 19-27 https://www.scirp.org/journal/wjv ISSN Online: 2160-5823 ISSN Print: 2160-5815 Universal COVID-19 Vaccine Targeting SARS-CoV-2 Envelope Protein Chung-Min Tsai1,2 1Graduate Institute of Medical Sciences, Taipei Medical University, Taiwan 2MacKay Children’s Hospital, Taiwan How to cite this paper: Tsai, C.-M. (2021) Abstract Universal COVID-19 Vaccine Targeting SARS-CoV-2 Envelope Protein. World The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute Journal of Vaccines, 11, 19-27. respiratory syndrome coronavirus 2 (SARS-CoV-2), had caused over 382 mil- https://doi.org/10.4236/wjv.2021.113003 lion cases and over 2.7 million deaths globally as of 23 March 2021. By that Received: March 23, 2021 date, at least 10 SARS-CoV-2 variants had emerged. The transmissibility and Accepted: July 5, 2021 lethality of the variants are higher than those of the Wuhan reference strain. Published: July 8, 2021 Therefore, a universal vaccine for the reference strain and all variants (present and future) is indispensable. The coronavirus envelope (E) protein is Copyright © 2021 by author(s) and Scientific Research Publishing Inc. an integral membrane protein crucial to the viral lifecycle and the pathogene- This work is licensed under the Creative sis of coronaviruses. The SARS-CoV-2 E protein has a postsynaptic density Commons Attribution International protein 95/Drosophila disc large tumor suppressor/zonula occludens-1 (PDZ) License (CC BY 4.0). binding motif (PBM), and its interaction with PDZ-domain-2 of the human http://creativecommons.org/licenses/by/4.0/ tight junction protein may interrupt the integrity of lung epithelium.
    [Show full text]